BR9809189A - Compostos adequados para liberação controlada do hormÈnio gnrh e seus análogos - Google Patents

Compostos adequados para liberação controlada do hormÈnio gnrh e seus análogos

Info

Publication number
BR9809189A
BR9809189A BR9809189-1A BR9809189A BR9809189A BR 9809189 A BR9809189 A BR 9809189A BR 9809189 A BR9809189 A BR 9809189A BR 9809189 A BR9809189 A BR 9809189A
Authority
BR
Brazil
Prior art keywords
analogs
controlled release
gnrh
compounds suitable
gnrh hormone
Prior art date
Application number
BR9809189-1A
Other languages
English (en)
Inventor
Patrick J Burns
John W Gibson
Arthur J Tipton
Original Assignee
Southern Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26668592&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9809189(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Southern Biosystems Inc filed Critical Southern Biosystems Inc
Publication of BR9809189A publication Critical patent/BR9809189A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromonomer-Based Addition Polymer (AREA)

Abstract

"COMPOSTOS ADEQUADOS PARA LIBERAçãO CONTROLADA DO HORMÈNIO GnRH E SEUS ANáLOGOS". Composição líquida para a liberação controlada de hormónio de liberação de gonodotropina (GnRH) ou seus análogos é fornecida que inclui: (i) um material portador líquido não-solúvel em água, não-polimérico (HVLCM) ou viscosidade de pelo menos 5.000 cP a 37<198>C que não cristaliza puro sob condições ambiente ou fisiológica; e (ii) GnRH ou seus análogos.
BR9809189-1A 1997-05-28 1998-05-26 Compostos adequados para liberação controlada do hormÈnio gnrh e seus análogos BR9809189A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4778997P 1997-05-28 1997-05-28
US09/001,123 US6051558A (en) 1997-05-28 1997-12-30 Compositions suitable for controlled release of the hormone GnRH and its analogs
PCT/US1998/010668 WO1998053837A1 (en) 1997-05-28 1998-05-26 COMPOSITIONS SUITABLE FOR CONTROLLED RELEASE OF THE HORMONE GnRH AND ITS ANALOGS

Publications (1)

Publication Number Publication Date
BR9809189A true BR9809189A (pt) 2002-12-03

Family

ID=26668592

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809189-1A BR9809189A (pt) 1997-05-28 1998-05-26 Compostos adequados para liberação controlada do hormÈnio gnrh e seus análogos

Country Status (10)

Country Link
US (1) US6051558A (pt)
EP (1) EP1017411B1 (pt)
AT (1) ATE311196T1 (pt)
AU (1) AU743086C (pt)
BR (1) BR9809189A (pt)
CA (1) CA2291087C (pt)
DE (1) DE69832631T2 (pt)
ES (1) ES2255162T3 (pt)
NZ (1) NZ501219A (pt)
WO (1) WO1998053837A1 (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US20060025328A1 (en) * 1997-05-28 2006-02-02 Burns Patrick J Compositions suitable for controlled release of the hormone GnRH and its analogs
US6028057A (en) * 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
WO2000078335A1 (en) * 1999-06-18 2000-12-28 Southern Biosystems, Inc. COMPOSITIONS FOR CONTROLLED RELEASE OF THE HORMONE GnRH AND ITS ANALOGS
US7074803B2 (en) * 2001-03-02 2006-07-11 Durect Corporation Opioid formulations
ATE309822T1 (de) * 2000-04-19 2005-12-15 Genentech Inc Formulierungen mit verzögerter freisetzung enthaltend wachstumshormon
AU2001296770A1 (en) * 2000-10-06 2002-04-15 Durect Corporation Devices and methods for management of inflammation
EP1330257B1 (en) * 2000-10-30 2005-08-31 University Of Zurich Gnrh analogues for treatment of urinary incontinence
EP1365770A2 (en) * 2001-02-07 2003-12-03 Durect Corporation Devices and methods for management of bone density
AU2002320122B2 (en) * 2001-06-21 2007-07-26 Genentech, Inc. Sustained release formulation
AU2003216424A1 (en) * 2002-02-25 2003-10-08 Guilford Pharmaceuticals, Inc. Phosphorus-containing compounds with polymeric chains, and methods of making and using the same
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
ATE482695T1 (de) * 2002-12-13 2010-10-15 Durect Corp Orale darreichungsform mit flüssigen hochviskosen trägersystemen
EP3025722B1 (en) 2003-10-03 2020-05-27 Thorn BioScience, LLC Process for the synchronization of ovulation for timed breeding without heat detection
CA2552241C (en) * 2003-12-30 2013-10-01 Durect Corporation Co-polymeric devices for controlled release of active agents
BRPI0515372B8 (pt) * 2004-09-17 2021-05-25 Durect Corp composição líquida para fornecer anestesia local prolongada após administração a um indivíduo, e, uso de bupivacaína, acetato isobutirato de sacarose e álcool benzílico
US20080254086A1 (en) * 2004-12-23 2008-10-16 Brown James E Controlled Release Compositions
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US20080286375A1 (en) * 2005-11-15 2008-11-20 Amorepacific Corporation Method for Preparing Sustained-Release Microparticles Comprising Sucrose Acetate Isobutyrate
WO2007062483A1 (en) * 2005-12-02 2007-06-07 Parnell Laboratories (Aust) Pty Limited Increasing pregnancy rates
US20070197435A1 (en) * 2006-02-17 2007-08-23 Webel Stephen K Process for the synchronization of ovulation for timed breeding without heat detection
KR100908517B1 (ko) * 2006-07-04 2009-07-20 (주)아모레퍼시픽 호흡기계 약제 전달을 위한 서방형 다공성 미세입자 및 그제조 방법
PL2117521T3 (pl) 2006-11-03 2012-11-30 Durect Corp Transdermalne systemy dostarczania zawierające bupiwakainę
AU2007234612B2 (en) * 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
WO2009020744A1 (en) 2007-08-07 2009-02-12 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations comprising gdf-5 in aqueous acidic solution
WO2009075782A1 (en) * 2007-12-06 2009-06-18 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
US20090181068A1 (en) * 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
CN102131483A (zh) 2008-02-08 2011-07-20 昌达生物科技公司 可控给药非聚合组合物
JP5718058B2 (ja) 2008-02-08 2015-05-13 キューピーエス リミテッド ライアビリティ カンパニー タンパク質又はペプチドの徐放送達用組成物
BRPI0911048A2 (pt) * 2008-04-14 2015-12-29 Atrm Llc formulações líquidas tamponadas de gdf-5
EP2307040B1 (en) 2008-05-29 2015-09-09 Isr Immune System Regulation Ab Use of gnrh and sex hormones for treating viral disease, in particular hiv/aids
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
BR122013009981B1 (pt) 2009-04-23 2020-02-11 United-Ah Ii, Llc Composição para sincronizar o tempo de inseminação
AR082266A1 (es) 2011-05-13 2012-11-28 Univ Nac Del Litoral Microparticula inyectable de liberacion controlada
CN113398243A (zh) 2012-11-28 2021-09-17 联合动物健康第二有限责任公司 用于同步小母猪的授精时间的方法
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
EA201692083A1 (ru) 2014-04-16 2017-03-31 Вейкс-Фарма Гмбх Фармацевтическая композиция для ветеринарии и ее применение
AU2015258892A1 (en) * 2014-05-16 2016-11-17 Neuraltus Pharmaceuticals, Inc. Methods and compositions for treatment of macrophage-related disorders
CL2016000217A1 (es) * 2016-01-27 2016-07-01 Farmacologia En Aquacultura Veterinaria Fav S A Nueva composición veterinaria inyectable para la sincronización del desove en peces
US12274794B2 (en) 2016-07-06 2025-04-15 Orient Pharma Co., Ltd. Oral dosage form with drug composition, barrier layer and drug layer
CN111202837B (zh) * 2018-11-22 2022-02-08 中国农业大学 一种用于控制马属动物排卵的制剂及控制排卵的方法
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
CN116940358A (zh) 2021-01-12 2023-10-24 度勒科特公司 持续释放药物递送系统和有关的方法
CN113350275B (zh) * 2021-06-19 2022-09-06 江西农业大学 一种烯丙孕素缓释注射液及其制备方法和应用
AU2022334280A1 (en) 2021-08-25 2024-02-29 Reprologix Methods for reproductive management of sheep and goats

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411890A (en) * 1981-04-14 1983-10-25 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
NO139560C (no) * 1972-04-29 1979-04-04 Takeda Chemical Industries Ltd Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
CA1030526A (en) * 1973-11-01 1978-05-02 Samuel Wilkinson Biologically active amides
DE2438350C3 (de) * 1974-08-09 1979-06-13 Hoechst Ag, 6000 Frankfurt Peptide mit starker LH-RH/FSH-RH-Wirkung, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
GB1524747A (en) * 1976-05-11 1978-09-13 Ici Ltd Polypeptide
US5391381A (en) * 1987-06-25 1995-02-21 Alza Corporation Dispenser capable of delivering plurality of drug units
US5350741A (en) * 1988-07-30 1994-09-27 Kanji Takada Enteric formulations of physiologically active peptides and proteins
AU7880991A (en) * 1990-05-10 1991-11-27 Novo Nordisk A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
IT1240643B (it) * 1990-05-11 1993-12-17 Mediolanum Farmaceutici Spa Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano
ZA918168B (en) * 1990-10-16 1993-04-14 Takeda Chemical Industries Ltd Prolonged release preparation and polymers thereof.
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5487898A (en) * 1991-08-26 1996-01-30 Abbott Laboratories Compositions and method for the sublingual or buccal administration therapeutic agents
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
JP3313113B2 (ja) * 1991-10-21 2002-08-12 ペプテック リミテッド 雌馬の排卵制御用生体適合性インプラント
JPH07112940A (ja) * 1993-08-26 1995-05-02 Takeda Chem Ind Ltd 徐放性非経口投与製剤およびその製造方法
US5747058A (en) * 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
DE69634277T2 (de) * 1995-06-07 2006-01-05 Southern Biosystems, Inc., Birmingham Kontrolliertes zuführsystem mit einer flüssigkeit von hoher viskosität
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system

Also Published As

Publication number Publication date
US6051558A (en) 2000-04-18
DE69832631T2 (de) 2006-08-10
CA2291087C (en) 2009-12-29
EP1017411A1 (en) 2000-07-12
AU743086C (en) 2004-07-15
AU7598098A (en) 1998-12-30
WO1998053837A1 (en) 1998-12-03
CA2291087A1 (en) 1998-12-03
DE69832631D1 (de) 2006-01-05
EP1017411B1 (en) 2005-11-30
AU743086B2 (en) 2002-01-17
ES2255162T3 (es) 2006-06-16
ATE311196T1 (de) 2005-12-15
NZ501219A (en) 2002-03-01
EP1017411A4 (en) 2002-09-04

Similar Documents

Publication Publication Date Title
EP1017411A4 (en) COMPOSITIONS SUITABLE FOR THE CONTROLLED RELEASE OF THE HORMONE GNRH AND ITS ANALOG
DK1006935T3 (da) Styret afgivelsessystem med en væske med höj viskositet
ATE309822T1 (de) Formulierungen mit verzögerter freisetzung enthaltend wachstumshormon
NZ311208A (en) Composition comprising an active agent dissolved in a glass-forming carrier comprising a glass-forming substance containing a plasticizer, composition is liquid or jelly-like below 50 degrees
GR3035150T3 (en) Compounds with growth hormone releasing properties
ES2114931T3 (es) Nuevos esteres esteroidales.
BR0009830A (pt) Composições para cuidados com a pele contendo uma combinação de substâncias ativas para cuidados com a pele
ES2099047T1 (es) Compuesto de sales opticamente puras de piridinilmetil, sulfinil, bencimidazol.
GEP20022709B (en) Pharmaceutical Compositions Having Appetite Suppressant Activity
MX9709278A (es) Dipeptidos que promueven la liberacion de la hormona de crecimiento, composiciones que los contienen y uso de los mismos.
GB2364304A (en) Novel tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them
BR9913457A (pt) Neuroproteção
ES2062375T3 (es) Composiciones farmaceuticas que contienen un complejo de zinc.
ATE233086T1 (de) Wirkstoffhaltige pflaster
BR9806805A (pt) Mistura sólida, e, processos para controlar o crescimento de plantas indesejáveis e para preparar formulações de herbicidas.
BR9912706A (pt) Composições farmacêuticas contendo ibuprofeno e domperidona
HU9700842D0 (en) Pharmaceutical compositions based on stabilized lipophyl matrix giving controlled release for the active components
IE830282L (en) Ergot alkaloids
FR2703908B1 (fr) Forme pharmaceutique pour administration rectale de composés pharmacologiquement actifs.
RU94040720A (ru) Экстроген (прогестин) антипрогестиновый, способ пероральной контрацепции и регулирования менструаций, фармацевтическая композиция и набор лекарственных средств
KR930005615A (ko) 페이스트 및 페이스트 제제
MX9710377A (es) Compuestos con propiedades de liberacion de la hormona de crecimiento.
JPS57134413A (en) Percutaneous absorbable drug and product containing the same
AR023938A1 (es) Composiciones estables de aminobutironitrilo quiral.
GB2014849A (en) Compositions containing an anti- depressant and a tranquiliser

Legal Events

Date Code Title Description
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: SEGUNDO O ART. 13 DA LPI 9279 DE 14/05/1996 O PRESENTE PEDIDO NAO APRESENTA ATIVIDADE INVENTIVA, NAO ATENDENDO, PORTANTO, AOS REQUISITOS DE PATENTEABILIDADE, CONFORME DETERMINA O ART. 8O DA LPI 9279 DE 14/05/1996.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]